Author: John Scott Lewinski Forbes A concerning new study reports the majority of millennials and members of Generation Z rely first on social media platforms for their health information. A situation made necessary partly by quarantine conditions, it would indicate those age groups are at the mercy of social media sources’ sometimes dubious accuracy. The […]
Read MoreDG Alerts According to a large-scale retrospective analysis published in the International Journal of Infectious Diseases, treatment with hydroxychloroquine alone and in combination with azithromycin was associated with a significant reduction in mortality among patients hospitalized with COVID-19 in a strictly monitored protocol-driven in-hospital setting. “The benefits of hydroxychloroquine in our cohort as compared to previous […]
Read MoreBy E.J. Mundell HealthDay Doctors have long noted links between severe COVID-19 and heart trouble, but a new study helps quantify the magnitude of the problem. The study of hundreds of hospitalized patients found that cardiac arrest and heart rhythm disorders are 10 times more common among COVID-19 patients requiring intensive care than among other […]
Read MoreDefinitive Healthcare According to military.com, Gene Wamsley has been arrested and charged with theft of government property after stealing respirators from the VA Medical Center in Seattle, where he worked until June 9, 2020, and then selling them online using an eBay account. At first, Wamsley denied the allegations but eventually confessed to the crimes. […]
Read MoreMedicalNewsToday New research suggests that in the United States, around 35% of excess deaths during the early phase of the pandemic were not directly caused by COVID-19. A new study has found that in the U.S., up to 35% of excess deaths during the early phase of the pandemic may not have been directly due […]
Read MoreDG Alerts Low mortality rate observed in a small case series published in Critical Care suggests that combination treatment of favipiravir and nafamostat mesylate may be effective for critically ill coronavirus disease 2019 (COVID-19) patients. “Nafamostat mesylate therapy in combination with favipiravir may allow blockade of virus entry and replication, as well as inhibition of pathogenic host […]
Read MoreAUTHORS: Hanidziar, Dusan MD, PhD et al Anesthesia & Analgesia: July 2020 – Volume 131 – Issue 1 – p e40-e41 To the Editor Management of patient sedation and analgesia to alleviate anxiety and pain and facilitate mechanical ventilation is one of the key roles of every intensivist. During the coronavirus disease 2019 (COVID-19) pandemic, […]
Read MoreAuthor: Michael Walter Cardiovascular Business A new study suggests COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. The researchers found that SARS-CoV-2, the virus behind COVID-19, was capable of infecting heart muscle cells created with stem cell technology and stored in a lab dish. They […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association. Such stress is already considered a risk factor for a variety of atherosclerotic diseases. More than 200 million people around the world suffer from […]
Read MoreModern Healthcare News The personal protective gear that was in dangerously short supply during the early weeks of the coronavirus crisis in the U.S. is running low again as the virus resumes its rapid spread and the number of hospitalized patients climbs. A national nursing union is concerned that gear has to be reused. A […]
Read More